Metropolitan Life Insurance CO Chimerix Inc Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$1.67 - $2.35 $8,794 - $12,375	5,266 New	5,266 $9.8 Million
Q4 2022 Mar 30, 2023	BUY	$1.67 - $2.35 $467 - $658	280 Added 5.62%	5,266 $9,000
Q4 2022 Feb 15, 2023	BUY	$1.67 - $2.35 $8,794 - $12,375	5,266 New	5,266 $9,000
Q2 2022 Aug 11, 2022	SELL	$1.34 - $5.34 $6,681 - $26,625	-4,986 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$4.58 - $6.8 $22,835 - $33,904	4,986 New	4,986 $22,000
Q1 2022 Mar 30, 2023	SELL	$4.58 - $6.8 $37,230 - $55,277	-8,129 Reduced 61.98%	4,986 $22,000
Q1 2022 May 12, 2022	SELL	$4.58 - $6.8 $37,230 - $55,277	-8,129 Reduced 61.98%	4,986 $23,000
Q4 2021 Jun 21, 2023	BUY	$5.23 - $7.18 $68,591 - $94,165	13,115 New	13,115 $84,000
Q4 2021 Mar 30, 2023	BUY	$5.23 - $7.18 $17,232 - $23,658	3,295 Added 33.55%	13,115 $84,000
Q4 2021 Feb 15, 2022	BUY	$5.23 - $7.18 $17,232 - $23,658	3,295 Added 33.55%	13,115 $84,000
Q3 2021 Jun 21, 2023	BUY	$5.94 - $8.75 $58,330 - $85,925	9,820 New	9,820 $60,000
Q3 2021 Mar 30, 2023	SELL	$5.94 - $8.75 $47,098 - $69,378	-7,929 Reduced 44.67%	9,820 $60,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $47,098 - $69,378	-7,929 Reduced 44.67%	9,820 $61,000
Q2 2021 Jun 21, 2023	BUY	$7.54 - $9.79 $133,827 - $173,762	17,749 New	17,749 $141,000
Q2 2021 Mar 30, 2023	BUY	$7.54 - $9.79 $13,768 - $17,876	1,826 Added 11.47%	17,749 $141,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $133,706 - $173,606	17,733 Added 110831.25%	17,749 $142,000
Q1 2021 Jun 26, 2023	BUY	$4.76 - $11.25 $75,793 - $179,133	15,923 New	15,923 $153 Million
Q1 2021 Mar 30, 2023	BUY	$4.76 - $11.25 $50,727 - $119,891	10,657 Added 202.37%	15,923 $153,000
Q1 2021 May 14, 2021	BUY	$4.76 - $11.25 $76 - $180	16 New	16 $153,000
Q2 2018 Aug 15, 2018	SELL	$4.43 - $5.14 $75,832 - $87,986	-17,118 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $79,598 - $100,996	17,118 New	17,118 $0
Q4 2017 Feb 15, 2018	SELL	$4.32 - $5.52 $152,677 - $195,087	-35,342 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$4.35 - $5.25 $530 - $640	-122 Reduced 0.34%	35,342 $186,000
Q2 2017 Aug 14, 2017	BUY	N/A	35,464	35,464 $193,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account